Grilled by Congress, Kennedy defends NIH and NCI budget cuts, freezes, and RIFs To avoid “offending” pharma, NCI doesn’t study the causes of early-onset colon cancer, HHS secretary incorrectly alleges

FDA clears a way for dramatic reduction in animal toxicology studies in cancer

FDA has issued a draft guidance to reduce unnecessary animal testing in nonclinical safety assessments for some cancer pharmaceuticals.

June 18, 2026

Vol.52 No.24

By Claire Marie Porter

Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”

The White House Office of Management and Budget has published a “Regulation for Federal Financial Assistance,” a proposed rule that seeks to fundamentally redraw the ground rules for all federally funded research. On the other side are America’s scientists who aren’t just crying foul—they are readying for a political fight.

House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

On June 9, the House Appropriations Committee passed its version of the fiscal year 2027 spending bill for Labor, Health and Human Services, and Education.

NIH calls for comment on proposal to limit the number of RPGs per PI

NIH has published a request for information on its proposed policy that would cap the number of research project grants, or RPGs, for which an individual can simultaneously serve as principal investigator or multi-principal investigator.

UCLA researchers awarded $3.2M NIH grant to develop AI tool for more personalized liver cancer treatment

Jason Chiang and Kyung Sung of the Department of Radiological Sciences at the David Geffen School of Medicine at UCLA and the UCLA Health Jonsson Comprehensive Cancer Center have received a $3.2 million, five-year grant from NCI to develop an artificial intelligence-enhanced imaging platform designed to improve yttrium-90 (Y90) radioembolization planning for patients with liver cancer.

June 05, 2026

Vol.52 No.22

Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer

Top HHS officials last week called for a “moonshot” focused on the role of the microbiome in cancer.

May 22, 2026

Vol.52 No.20

By Paul Goldberg

Grilled by Congress, Kennedy defends NIH and NCI budget cuts, freezes, and RIFs

To avoid “offending” pharma, NCI doesn’t study the causes of early-onset colon cancer, HHS secretary incorrectly alleges

YOU MAY BE INTERESTED IN

FDA clears a way for dramatic reduction in animal toxicology studies in cancer

Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”

House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

NIH calls for comment on proposal to limit the number of RPGs per PI

UCLA researchers awarded $3.2M NIH grant to develop AI tool for more personalized liver cancer treatment

Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer

Renew today!

Subscriber content

Never miss an issue!

Login

Grilled by Congress, Kennedy defends NIH and NCI budget cuts, freezes, and RIFs

To avoid “offending” pharma, NCI doesn’t study the causes of early-onset colon cancer, HHS secretary incorrectly alleges

YOU MAY BE INTERESTED IN

FDA clears a way for dramatic reduction in animal toxicology studies in cancer

Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”

House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

NIH calls for comment on proposal to limit the number of RPGs per PI

UCLA researchers awarded $3.2M NIH grant to develop AI tool for more personalized liver cancer treatment

Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer

Never miss an issue!

Login

Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”